An estimated three million Canadians are now taking GLP-1 medications, with weight loss cited as the leading reason people take or are considering taking them, according to a 2026 Leger survey. But ...
Tool count used to be the consolidation scorecard. In 2026, it's data gravity — and it's dragging CDP vendors toward a reckoning. A marketing team's data stack works a lot like a building's plumbing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results